APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DTIs for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DTIs for Injection Industry Growth and Trends Forecast to 2032

Report ID 173986830128 December 2025116 pages

Choose your research edition.

Industry ResearchDTIs for Injection Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal DTIs for Injection Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal DTIs for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DTIs for Injection Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal DTIs for Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global DTIs for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DTIs for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DTIs for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DTIs for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DTIs for Injection include Yangtze River Pharmaceutical, Beijing SL Pharmaceutical, CSPC Ouyi Pharmaceutical, Lunan Pharmaceutical, BrightGene, The Medicines Company, Teva Pharmaceutical, Sandoz and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DTIs for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DTIs for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DTIs for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DTIs for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DTIs for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DTIs for Injection Market by Company

Yangtze River Pharmaceutical

Beijing SL Pharmaceutical

CSPC Ouyi Pharmaceutical

Lunan Pharmaceutical

BrightGene

The Medicines Company

Teva Pharmaceutical

Sandoz

Pfizer

Mitsubishi Tanabe Pharma

GlaxoSmithKline

Eugia Pharma

Dr.Reddy's Laboratories

Aurobindo Pharma

Apotex

Accord Healthcare

DTIs for Injection Segment by Type

Argatroban

Bivalirudin

Other

DTIs for Injection Segment by Application

Pulmonary Embolism

Deep Vein Thrombosis

Atrial Fibrillation

Other

DTIs for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTIs for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DTIs for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTIs for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DTIs for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DTIs for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Argatroban Table 2. Major Company of Bivalirudin Table 3. Major Company of Other Table 4. Global DTIs for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 6. Global DTIs for Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global DTIs for Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global DTIs for Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global DTIs for Injection Sales by Type (2027-2032) & (K Units) Table 11. Global DTIs for Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global DTIs for Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global DTIs for Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global DTIs for Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 16. North America DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa DTIs for Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa DTIs for Injection Sales by Type (2021-2026) & (US$ Million) Table 25. DTIs for Injection Industry Trends Table 26. DTIs for Injection Industry Drivers Table 27. DTIs for Injection Industry Opportunities and Challenges Table 28. DTIs for Injection Industry Restraints Table 29. Global DTIs for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global DTIs for Injection Revenue Market Share by Company (2021-2026) Table 31. Global DTIs for Injection Sales by Company (2021-2026) & (K Units) Table 32. Global DTIs for Injection Sales Share by Company (2021-2026) Table 33. Global DTIs for Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global DTIs for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global DTIs for Injection Major Company Production Sites and Headquarters Table 36. Global DTIs for Injection Company, Product Type & Application Table 37. Global DTIs for Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global DTIs for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global DTIs for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global DTIs for Injection Sales by Region (2021-2026) & (K Units) Table 42. Global DTIs for Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global DTIs for Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global DTIs for Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global DTIs for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global DTIs for Injection Sales by Region (2027-2032) & (K Units) Table 47. Global DTIs for Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global DTIs for Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global DTIs for Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global DTIs for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global DTIs for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 53. Global DTIs for Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global DTIs for Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global DTIs for Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global DTIs for Injection Sales by Application (2027-2032) & (K Units) Table 58. Global DTIs for Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global DTIs for Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global DTIs for Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global DTIs for Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 63. North America DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa DTIs for Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa DTIs for Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Yangtze River Pharmaceutical Company Information Table 73. Yangtze River Pharmaceutical Business Overview Table 74. Yangtze River Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Yangtze River Pharmaceutical DTIs for Injection Product Portfolio Table 76. Yangtze River Pharmaceutical Recent Development Table 77. Beijing SL Pharmaceutical Company Information Table 78. Beijing SL Pharmaceutical Business Overview Table 79. Beijing SL Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Beijing SL Pharmaceutical DTIs for Injection Product Portfolio Table 81. Beijing SL Pharmaceutical Recent Development Table 82. CSPC Ouyi Pharmaceutical Company Information Table 83. CSPC Ouyi Pharmaceutical Business Overview Table 84. CSPC Ouyi Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CSPC Ouyi Pharmaceutical DTIs for Injection Product Portfolio Table 86. CSPC Ouyi Pharmaceutical Recent Development Table 87. Lunan Pharmaceutical Company Information Table 88. Lunan Pharmaceutical Business Overview Table 89. Lunan Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lunan Pharmaceutical DTIs for Injection Product Portfolio Table 91. Lunan Pharmaceutical Recent Development Table 92. BrightGene Company Information Table 93. BrightGene Business Overview Table 94. BrightGene DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. BrightGene DTIs for Injection Product Portfolio Table 96. BrightGene Recent Development Table 97. The Medicines Company Company Information Table 98. The Medicines Company Business Overview Table 99. The Medicines Company DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. The Medicines Company DTIs for Injection Product Portfolio Table 101. The Medicines Company Recent Development Table 102. Teva Pharmaceutical Company Information Table 103. Teva Pharmaceutical Business Overview Table 104. Teva Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Pharmaceutical DTIs for Injection Product Portfolio Table 106. Teva Pharmaceutical Recent Development Table 107. Sandoz Company Information Table 108. Sandoz Business Overview Table 109. Sandoz DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sandoz DTIs for Injection Product Portfolio Table 111. Sandoz Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer DTIs for Injection Product Portfolio Table 116. Pfizer Recent Development Table 117. Mitsubishi Tanabe Pharma Company Information Table 118. Mitsubishi Tanabe Pharma Business Overview Table 119. Mitsubishi Tanabe Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Mitsubishi Tanabe Pharma DTIs for Injection Product Portfolio Table 121. Mitsubishi Tanabe Pharma Recent Development Table 122. GlaxoSmithKline Company Information Table 123. GlaxoSmithKline Business Overview Table 124. GlaxoSmithKline DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GlaxoSmithKline DTIs for Injection Product Portfolio Table 126. GlaxoSmithKline Recent Development Table 127. Eugia Pharma Company Information Table 128. Eugia Pharma Business Overview Table 129. Eugia Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Eugia Pharma DTIs for Injection Product Portfolio Table 131. Eugia Pharma Recent Development Table 132. Dr.Reddy's Laboratories Company Information Table 133. Dr.Reddy's Laboratories Business Overview Table 134. Dr.Reddy's Laboratories DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Dr.Reddy's Laboratories DTIs for Injection Product Portfolio Table 136. Dr.Reddy's Laboratories Recent Development Table 137. Aurobindo Pharma Company Information Table 138. Aurobindo Pharma Business Overview Table 139. Aurobindo Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Aurobindo Pharma DTIs for Injection Product Portfolio Table 141. Aurobindo Pharma Recent Development Table 142. Apotex Company Information Table 143. Apotex Business Overview Table 144. Apotex DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Apotex DTIs for Injection Product Portfolio Table 146. Apotex Recent Development Table 147. Accord Healthcare Company Information Table 148. Accord Healthcare Business Overview Table 149. Accord Healthcare DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Accord Healthcare DTIs for Injection Product Portfolio Table 151. Accord Healthcare Recent Development Table 152. North America DTIs for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. North America DTIs for Injection Sales by Country (2021-2026) & (K Units) Table 154. North America DTIs for Injection Sales Market Share by Country (2021-2026) Table 155. North America DTIs for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 156. North America DTIs for Injection Sales Market Share Forecast by Country (2027-2032) Table 157. North America DTIs for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America DTIs for Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. North America DTIs for Injection Market Share by Country (2021-2026) Table 160. North America DTIs for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America DTIs for Injection Market Share Forecast by Country (2027-2032) Table 162. Europe DTIs for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Europe DTIs for Injection Sales by Country (2021-2026) & (K Units) Table 164. Europe DTIs for Injection Sales Market Share by Country (2021-2026) Table 165. Europe DTIs for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 166. Europe DTIs for Injection Sales Market Share Forecast by Country (2027-2032) Table 167. Europe DTIs for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe DTIs for Injection Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe DTIs for Injection Market Share by Country (2021-2026) Table 170. Europe DTIs for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe DTIs for Injection Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific DTIs for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific DTIs for Injection Sales by Country (2021-2026) & (K Units) Table 174. Asia-Pacific DTIs for Injection Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific DTIs for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 176. Asia-Pacific DTIs for Injection Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific DTIs for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific DTIs for Injection Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific DTIs for Injection Market Share by Country (2021-2026) Table 180. Asia-Pacific DTIs for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific DTIs for Injection Market Share Forecast by Country (2027-2032) Table 182. Latin America DTIs for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Latin America DTIs for Injection Sales by Country (2021-2026) & (K Units) Table 184. Latin America DTIs for Injection Sales Market Share by Country (2021-2026) Table 185. Latin America DTIs for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 186. Latin America DTIs for Injection Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America DTIs for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America DTIs for Injection Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America DTIs for Injection Market Share by Country (2021-2026) Table 190. Latin America DTIs for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America DTIs for Injection Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa DTIs for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa DTIs for Injection Sales by Country (2021-2026) & (K Units) Table 194. Middle East and Africa DTIs for Injection Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa DTIs for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 196. Middle East and Africa DTIs for Injection Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa DTIs for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa DTIs for Injection Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa DTIs for Injection Market Share by Country (2021-2026) Table 200. Middle East and Africa DTIs for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa DTIs for Injection Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. DTIs for Injection Distributors List Table 205. DTIs for Injection Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. DTIs for Injection Image Figure 2. Global DTIs for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DTIs for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global DTIs for Injection Sales (2021-2032) & (K Units) Figure 5. Argatroban Image Figure 6. Global Argatroban Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bivalirudin Image Figure 8. Global Bivalirudin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global DTIs for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global DTIs for Injection Market Share by Type 2025 VS 2032 Figure 13. North America DTIs for Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America DTIs for Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe DTIs for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe DTIs for Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific DTIs for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific DTIs for Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America DTIs for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America DTIs for Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa DTIs for Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa DTIs for Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 DTIs for Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pulmonary Embolism Image Figure 26. Global Pulmonary Embolism Sales YoY Growth (2021-2032) & (K Units) Figure 27. Deep Vein Thrombosis Image Figure 28. Global Deep Vein Thrombosis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Atrial Fibrillation Image Figure 30. Global Atrial Fibrillation Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global DTIs for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global DTIs for Injection Market Share by Application 2025 VS 2032 Figure 35. North America DTIs for Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America DTIs for Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe DTIs for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe DTIs for Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific DTIs for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific DTIs for Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America DTIs for Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America DTIs for Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa DTIs for Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa DTIs for Injection Sales Market Share in Value by Application in 2025 Figure 45. North America DTIs for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America DTIs for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America DTIs for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America DTIs for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe DTIs for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe DTIs for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe DTIs for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe DTIs for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific DTIs for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific DTIs for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific DTIs for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific DTIs for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America DTIs for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America DTIs for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America DTIs for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America DTIs for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa DTIs for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa DTIs for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa DTIs for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa DTIs for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. DTIs for Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. DTIs for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Argatroban
  • Bivalirudin
  • Other
Applications
  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Atrial Fibrillation
  • Other
Companies covered
  • Yangtze River Pharmaceutical
  • Beijing SL Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Lunan Pharmaceutical
  • BrightGene
  • The Medicines Company
  • Teva Pharmaceutical
  • Sandoz
  • Pfizer
  • Mitsubishi Tanabe Pharma
  • GlaxoSmithKline
  • Eugia Pharma
  • Dr.Reddy's Laboratories
  • Aurobindo Pharma
  • Apotex
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DTIs for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DTIs for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DTIs for Injection Market by Type
  6. 1.3.1 Argatroban
  7. 1.3.2 Bivalirudin
  8. 1.3.3 Other
  9. 1.4 Global DTIs for Injection Market Size by Type
  10. 1.4.1 Global DTIs for Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global DTIs for Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global DTIs for Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America DTIs for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe DTIs for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific DTIs for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America DTIs for Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa DTIs for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DTIs for Injection Industry Trends
  2. 2.2 DTIs for Injection Industry Drivers
  3. 2.3 DTIs for Injection Industry Opportunities and Challenges
  4. 2.4 DTIs for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DTIs for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by DTIs for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by DTIs for Injection Price (2021-2026)
  4. 3.4 Global DTIs for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DTIs for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global DTIs for Injection Company, Product Type & Application
  7. 3.7 Global DTIs for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DTIs for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DTIs for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DTIs for Injection Tier 1, Tier 2, and Tier 3
4 DTIs for Injection Regional Status and Outlook
  1. 4.1 Global DTIs for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DTIs for Injection Historic Market Size by Region
  3. 4.2.1 Global DTIs for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DTIs for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DTIs for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DTIs for Injection Forecasted Market Size by Region
  7. 4.3.1 Global DTIs for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DTIs for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DTIs for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DTIs for Injection by Application
  1. 5.1 DTIs for Injection Market by Application
  2. 5.1.1 Pulmonary Embolism
  3. 5.1.2 Deep Vein Thrombosis
  4. 5.1.3 Atrial Fibrillation
  5. 5.1.4 Other
  6. 5.2 Global DTIs for Injection Market Size by Application
  7. 5.2.1 Global DTIs for Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global DTIs for Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global DTIs for Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America DTIs for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe DTIs for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific DTIs for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America DTIs for Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa DTIs for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yangtze River Pharmaceutical
  2. 6.1.1 Yangtze River Pharmaceutical Company Information
  3. 6.1.2 Yangtze River Pharmaceutical Business Overview
  4. 6.1.3 Yangtze River Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yangtze River Pharmaceutical DTIs for Injection Product Portfolio
  6. 6.1.5 Yangtze River Pharmaceutical Recent Developments
  7. 6.2 Beijing SL Pharmaceutical
  8. 6.2.1 Beijing SL Pharmaceutical Company Information
  9. 6.2.2 Beijing SL Pharmaceutical Business Overview
  10. 6.2.3 Beijing SL Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing SL Pharmaceutical DTIs for Injection Product Portfolio
  12. 6.2.5 Beijing SL Pharmaceutical Recent Developments
  13. 6.3 CSPC Ouyi Pharmaceutical
  14. 6.3.1 CSPC Ouyi Pharmaceutical Company Information
  15. 6.3.2 CSPC Ouyi Pharmaceutical Business Overview
  16. 6.3.3 CSPC Ouyi Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSPC Ouyi Pharmaceutical DTIs for Injection Product Portfolio
  18. 6.3.5 CSPC Ouyi Pharmaceutical Recent Developments
  19. 6.4 Lunan Pharmaceutical
  20. 6.4.1 Lunan Pharmaceutical Company Information
  21. 6.4.2 Lunan Pharmaceutical Business Overview
  22. 6.4.3 Lunan Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lunan Pharmaceutical DTIs for Injection Product Portfolio
  24. 6.4.5 Lunan Pharmaceutical Recent Developments
  25. 6.5 BrightGene
  26. 6.5.1 BrightGene Company Information
  27. 6.5.2 BrightGene Business Overview
  28. 6.5.3 BrightGene DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BrightGene DTIs for Injection Product Portfolio
  30. 6.5.5 BrightGene Recent Developments
  31. 6.6 The Medicines Company
  32. 6.6.1 The Medicines Company Company Information
  33. 6.6.2 The Medicines Company Business Overview
  34. 6.6.3 The Medicines Company DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 The Medicines Company DTIs for Injection Product Portfolio
  36. 6.6.5 The Medicines Company Recent Developments
  37. 6.7 Teva Pharmaceutical
  38. 6.7.1 Teva Pharmaceutical Company Information
  39. 6.7.2 Teva Pharmaceutical Business Overview
  40. 6.7.3 Teva Pharmaceutical DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical DTIs for Injection Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz DTIs for Injection Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer DTIs for Injection Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Mitsubishi Tanabe Pharma
  56. 6.10.1 Mitsubishi Tanabe Pharma Company Information
  57. 6.10.2 Mitsubishi Tanabe Pharma Business Overview
  58. 6.10.3 Mitsubishi Tanabe Pharma DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mitsubishi Tanabe Pharma DTIs for Injection Product Portfolio
  60. 6.10.5 Mitsubishi Tanabe Pharma Recent Developments
  61. 6.11 GlaxoSmithKline
  62. 6.11.1 GlaxoSmithKline Company Information
  63. 6.11.2 GlaxoSmithKline Business Overview
  64. 6.11.3 GlaxoSmithKline DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline DTIs for Injection Product Portfolio
  66. 6.11.5 GlaxoSmithKline Recent Developments
  67. 6.12 Eugia Pharma
  68. 6.12.1 Eugia Pharma Company Information
  69. 6.12.2 Eugia Pharma Business Overview
  70. 6.12.3 Eugia Pharma DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Eugia Pharma DTIs for Injection Product Portfolio
  72. 6.12.5 Eugia Pharma Recent Developments
  73. 6.13 Dr.Reddy's Laboratories
  74. 6.13.1 Dr.Reddy's Laboratories Company Information
  75. 6.13.2 Dr.Reddy's Laboratories Business Overview
  76. 6.13.3 Dr.Reddy's Laboratories DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dr.Reddy's Laboratories DTIs for Injection Product Portfolio
  78. 6.13.5 Dr.Reddy's Laboratories Recent Developments
  79. 6.14 Aurobindo Pharma
  80. 6.14.1 Aurobindo Pharma Company Information
  81. 6.14.2 Aurobindo Pharma Business Overview
  82. 6.14.3 Aurobindo Pharma DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aurobindo Pharma DTIs for Injection Product Portfolio
  84. 6.14.5 Aurobindo Pharma Recent Developments
  85. 6.15 Apotex
  86. 6.15.1 Apotex Company Information
  87. 6.15.2 Apotex Business Overview
  88. 6.15.3 Apotex DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Apotex DTIs for Injection Product Portfolio
  90. 6.15.5 Apotex Recent Developments
  91. 6.16 Accord Healthcare
  92. 6.16.1 Accord Healthcare Company Information
  93. 6.16.2 Accord Healthcare Business Overview
  94. 6.16.3 Accord Healthcare DTIs for Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Accord Healthcare DTIs for Injection Product Portfolio
  96. 6.16.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America DTIs for Injection Sales by Country
  2. 7.1.1 North America DTIs for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DTIs for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America DTIs for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America DTIs for Injection Market Size by Country
  6. 7.2.1 North America DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DTIs for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America DTIs for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DTIs for Injection Sales by Country
  2. 8.1.1 Europe DTIs for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DTIs for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe DTIs for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DTIs for Injection Market Size by Country
  6. 8.2.1 Europe DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DTIs for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe DTIs for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DTIs for Injection Sales by Country
  2. 9.1.1 Asia-Pacific DTIs for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DTIs for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DTIs for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DTIs for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DTIs for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DTIs for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DTIs for Injection Sales by Country
  2. 10.1.1 South America DTIs for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DTIs for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America DTIs for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America DTIs for Injection Market Size by Country
  6. 10.2.1 South America DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DTIs for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America DTIs for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DTIs for Injection Sales by Country
  2. 11.1.1 Middle East and Africa DTIs for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DTIs for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DTIs for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DTIs for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa DTIs for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DTIs for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DTIs for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DTIs for Injection Value Chain Analysis
  2. 12.1.1 DTIs for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DTIs for Injection Production Mode & Process
  7. 12.2 DTIs for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DTIs for Injection Distributors
  10. 12.2.3 DTIs for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst